NHS England approves three new specialised treatments
NHS England has approved NHS funding for three new specialised treatments and services in the first of two prioritisation rounds.
Read More
Tag: Stevens-Johnson
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
